Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Date:

October 16, 2024

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

Source link

Amazon, Google make dueling nuclear investments to power data centers with clean energy

Leeds duo Daniel James and Manor Solomon return from injury absences

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Recent posts

Two Magnificent Seven companies report this week. Only one will likely be among the biggest profit drivers.

Walgreens Boots Alliance’s stock slides after profit miss and lowered guidance

Oil prices lifted by report Iran may be planning another major strike on Israel

General Mills to sell North American yogurt business to French dairy companies for $2.1 billion

Prescription-drug middlemen face mounting bipartisan criticism on Capitol Hill

Another billionaire investor positions for a Trump win. He’s placing ‘inflation trades.’

Live Nation says it’s winning over casual fans, even as they grapple with higher prices

B. Riley’s stock rallies 26% after founder offers to buy rest of troubled bank for $7 a share

5 stock-market takeaways as Biden sees ‘incredible pressure’ to step aside after debate

Nvidia’s bonds in demand heading into earnings, as investors eye companies expected to benefit from AI spending

Disney’s slowing park attendance will weigh on the stock for the next 12 to 18 months, analysts say

Trump floats manufacturing ambassador, while his Deere tariff threat draws flak from Mark Cuban

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Harris sees ‘next generation of breakthroughs’ built by U.S. workers. AI, crypto could benefit.

PepsiCo probably raised its prices too much, and now it’ll have to pay, analyst says

Related articles

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Company

Follow us